Simple single-gene disorders in humans can be genetically mapped by using traditional methods of linkage analysis and increasingly abundant restriction fragment length polymorphisms (RFLPs). Many human diseases and traits, however, can be expected to be genetically heterogeneous (i.e., caused by any one of several genes), and traditional linkage analysis is much less effective in such circumstances. We present two methods, interval mapping and simultaneous search, designed to exploit the full power of a linkage map of the DNA markers. For the simplest situations, only V3 as many affected families are needed to map a heterogeneous trait by using these methods. Only Vs-Vso as many are needed to detect that genetic heterogeneity is present.
Since the idea was proposed (1) , the use of DNA restriction fragment length polymorphisms (RFLPs) as genetic markers in human linkage studies has become common. A number of diseases that display simple Mendelian inheritance, but whose molecular etiology is unknown, have been genetically shown to be closely linked to RFLP loci and thereby localized to specific chromosomal regions. These include the autosomal dominant diseases Huntington disease (2) and polycystic kidney disease (3) , the autosomal recessive cystic fibrosis (4) (5) (6) (7) , and the chromosome X-linked recessive Duchenne muscular dystrophy (8) . In each case, randomly chosen RFLP probes were tested one at a time for linkage to the disease, using traditional methods (9, 10) .
Many, perhaps most, human diseases and biologically interesting traits, however, show more complex modes of transmission, including genetic heterogeneity, variable penetrance, polygenic inheritance, and altogether noninherited forms. Potential examples range from familial cancers and ataxia-telangiectasia to genetic forms of alcoholism and psychological disorders, if indeed any exist. Success in the case of simple Mendelian inheritance raises the hope that the RFLP approach can be used to elucidate these traits as well. Unfortunately, traditional single-marker methods are inefficient for analyzing such complicated patterns of inheritance.
Our purpose here is to explore an alternative approach: using a complete RFLP linkage map of the human genome.
The construction of such a map is feasible (11, 12) and is already well underway (13, 14) . By exploiting the full power of such a complete RFLP linkage map, we believe we may significantly reduce the number of families required for studying complex traits.
In this paper, we consider genetic heterogeneity. If a phenotype can be caused by mutations at any of several loci, it is said to be genetically heterogeneous. In well-studied organisms, such as the bacterium Escherichia coli, the yeast Saccharomyces cerevisiae, the nematode Caenorhabditis elegans, and the fruit fly Drosophila melanogaster, many phenotypes are genetically heterogeneous. Humans will likely be no different: in vitro complementation of cell lines suggests that xeroderma pigmentosum may be caused by mutations in as many as nine loci and ataxia-telangiectasia in as many as five (15) .
To see why genetic heterogeneity confounds single-marker linkage analysis, consider a marker at a recombination fraction 9 from a locus responsible for a fraction a of all occurrences of a heterogeneous trait. In the overall population, the chance that the marker will fail to cosegregate with the trait through a meiosis is the "apparent" recombination fraction 6' = Oa + ½2 (1 -a). Linkage will appear to be loose if a is small, even though 0 may be small. Detecting loose linkage requires many more observations than for tight linkage, since loose linkage more closely resembles the null hypothesis of nonlinkage. Moreover, even once linkage has been detected, there remains the thorny problem of disentangling the similar effects of high 6 and low a to obtain accurate estimates of these quantities: this is necessary both for locating the linked trait-causing gene and for testing whether the trait is actually heterogeneous (a < 1). The only distinction between close linkage to a heterogeneous trait and correspondingly more distant linkage to a homogeneous trait is that in the former case apparent crossovers will be preferentially clustered in a certain fraction a of the families examined (16, 17) . Detecting this clustering can require many, large pedigrees.
Neglecting to take account of even a modest degree of heterogeneity can result in missing a linkage entirely. For example, a trait-causing locus that accounts for 60% of all cases could lie within 1% of a marker and yet still be "excluded" by linkage analysis from a region of about 20% recombination fraction around the marker, if we were to assume (as is often done) that the trait is homogeneous.
We explore here two strategies designed to exploit the full power of an RFLP map to overcome these obstacles:
(i) Interval mapping. With a map, we may test whether a putative locus lies in an interval of known size between two adjacent markers. This is a more demanding hypothesis-and thus one easier to test-than whether the locus is linked to a single marker at an unknown distance.
(ii) Simultaneous search. Mapping just one of the loci causing a heterogeneous trait is inherently inefficient: the "signal" in cases due to the locus is swamped by the "noise" due to families segregating an unlinked locus. If we instead examine the several trait-causing loci simultaneously, we can extract a stronger, clearer "signal": in every family, at least one of the loci will appear to cosegregate with the disease.
Abbreviations: RFLP, restriction fragment length polymorphism; cM, centimorgan.
7353
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
DEFINITIONS AND ASSUMPTIONS
Mathematical Preliminaries. Comparing hypotheses in human genetics is typically done as follows (9, 10) . Given a pedigree, let X be the set of outcomes for the segregation in the pedigree of the markers of interest (say, a disease and an .RFLP to be tested for linkage) and letf1 andf2 be alternative probability distributions on X (corresponding, say, to linkage at 10% and nonlinkage). Each observation x E X yields odds ratio fi(x)/f2(x) in favor off, over f2. We make observations until the product of the odds ratios or, more conveniently, the sum of the log1o of the odds ratios, called the lod score, exceeds a predetermined threshold T (typically 3, corresponding to 1000:1 odds). Thus, if f' is in fact the correct distribution on X, the expected contribution to the lod score (Elod) from a single observation is correct hypothesis, then the expected lod score for Ho,, over H112,0 (nonlinkage) is E(Pn,ma; Pn,112,O). Table 1 shows the number of families needed to attain a lod score of 3, assuming recombination fractions of 10% and 20% from the nearest RFLP.** Detecting Linkage: Using Interval Mapping. Let M and Nbe adjacent RFLP loci at a known recombination distance A. Using the power of the map, we may test the hypothesis H' ,a: a locus L accounting for a fraction a of occurrences of the trait lies in the interval, at a recombination fraction rfrom
In mathematics, this is well known as the relative entropy or Kullback-Liebler distance (18) . The number of observations needed so that the expected aggregate lod score exceeds T is
T/E(f1, f2)
Assumptions About an RFLP Map. The human genome is about 3300 centimorgans long [1 centimorgan (cM) = 1% recombination]. For simplicity, we assume below the availability of a linkage map of "perfect" RFLPs, evenly spaced, with each RFLP so highly polymorphic that it is rarely found homozygous. Given 65 such RFLPs, defining intervals of size -52 cM, every region of the genome is within 20% recombinationi of an RFLP. Given 150, the intervals are =22 cM, and every locus is within 10%.
Since some 1000 RFLPs have already been discovered (11, 12) , including an increasing number of highly polymorphic ones, the eventual availability of such maps seems ensured. (In the interim, we may compensate for uneven spacing and incomplete polymorphism by increasing the number of RFLPs, families, or both: several nearby modestly polymorphic RFLPs can be thought of as equivalent to a single highly polymorphic one.)
INTERVAL MAPPING
We begin with a situation appropriate to mapping a dominant trait by using three-generation pedigrees: grandparents, parents, and n children. In this case, we can study n fully informative, phase-known meioses, one per child, provided the trait is fully penetrant. 1 1
Detecting Linkage: Using Unmapped Markers. Following Smith (19) , it is traditional to consider hypothesis He,,: that the recombination fraction is 0 between a single marker under study and a putative linked locus accounting for a fraction a of occurrences of the trait (with the rest due to an unlinked locus or a nongenetic cause). The possible outcomes for the segregation of the trait and the marker are observing 0, 1, 2,. . ., n crossovers. Assuming homogeneity (a = 1) and linkage at 6, the probability of i crossovers isp,, 6(i) = (7) Oi (1 -0)f-i Under heterogeneity, the probability is just the weighted average for linkage at 6 and nonlinkage: P,,,,a = ap,,, + (1 -a) Pn,1/2. If Ho,. is the $Here, as throughout, we assume the Haldane map function, corresponding to no crossover interference. Positive interference, for example at the Kosambi level, makes interval mapping slightly more efficient (data not shown). If penetrance is incomplete, unaffected children are of uncertain genotype. Thus, they add little to the analysis. In this case, n should be the number of affected children.
[Note that, given a map function, q, and X determine T'. With the Haldane function, if = r (1 -T') + T' (1 -4).1
A single phase-known meiosis results in one of four events: the allele inherited at L may be coinherited with in-phase alleles at both M and N, with probability PMN = (1 -T) (1 -T'); at Malone with probability PM = (1 -T)T'; at N alone with probability PN = T (1 -T'); at neither with probability po = eT'. The outcomes for a pedigree with n such phase-known meioses are identified by the numbers i, j, k, 1 of events of each type observed. Under homogeneity, the probability of such an outcome is
Under heterogeneity, the probability is again the weighted average p n,0,a = ap',o + (1 -a)p'n,1/2. The expected lod score and family resources required are computed as before.
The worst case occurs when L is midway between M and N; if so, call the recombination fraction to either marker 6. We may profitably rewrite the expected lod score in this case as [1] where y = 02/[02 + (1 -0)2]. There is a simple interpretation of Eq. 1: Chromosomes recombinant between M and N contribute zero expected information; only nonrecombinant meioses matter. The chance that there will be m such meioses is (n)41n-m(l -Em. Given such a meiosis, the chance that L will fail to cosegregate with the flanking markers is y, the (conditional) probability of a double crossover.
In short, the flanking markers are mathematically equivalent to a "virtual RFLP" at a recombination fraction y 0. The closer linkage of this virtual RFLP more than offsets the fact that only nonrecombinant meioses contribute information. Table 1 shows the resources needed to map a trait lying midway between two flanking RFLPs in 22-cM and 52-cM RFLP linkage maps (ice., at 10% or 20% from the flanking markers).
95% Certainty of Success. In planning a linkage study, it is prudent to collect more than just the average number of families needed to obtain a lod score of 3. Table 1 therefore shows the number required to ensure a 95% certainty of **More extensive tables for the case of single unmapped markers appear in ref. 16 . To facilitate comparison, we have employed the same recombination fractions and thresholds for detecting both linkage and heterogeneity.
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Detecting Heterogeneity: Using Unmapped Markers. Homogeneity is typically tested (10, 19) by comparing the maximum likelihood of the sample when we allow heterogeneity to the maximum likelihood when we insist on homogeneity. If the hypothesis He, is correct, the maximum likelihood allowing for heterogeneity occurs at (6, a), while the maximum likelihood under homogeneity occurs at some point (0*, 1). In the case of a dominant trait, it is intuitively plausible-and simple calculus confirms-that 6* is just the "apparent" recombination frequency: 6* = Oa + V2 (1 -a) , independent of n. Thus, to compare the hypotheses of heterogeneity and homogeneity, we are interested in the expected lod score E(pneOa; Pn*,l). The number of families needed to attain 10:1 odds in favor of Ho,a relative to He*,, appears in Table 1 .tt Detecting Heterogeneity: Using Interval Mapping. We adopt a similar approach in the case of mapped markers. Allowing for heterogeneity, the maximum likelihood occurs at the true values (r, a). If we insist on homogeneity, however, the maximum likelihood occurs at the midpoint of the intervalexcept if a is very close to 1, in which case the maximum occurs between the midpoint and the true location. The Elod is thus E(p', a; p'n,9,i), except for a close to 1 (a > 0.9, in our ftAs a working rule, odds of 10:1 seem appropriate for "indication" ofheterogeneity. We would propose a higher threshold for "proof"
of heterogeneity-at least 50:1. Searching for a Set of Loci. Usually, we will have no a priori beliefs about where the trait-causing loci will be. In this case, we may try all sets of k intervals in turn, in the manner just outlined. The only difference is that the threshold T for acceptance must be raised to account for an increased likelihood of false positives.
A simple Bayesian argument suggests an appropriate threshold. The a priori odds that a gene and a marker will be linked (at an effectively detectable distance) are about 50:1 against. Roughly, this is why Morton (9) prescribed that the data from a traditional linkage study must yield a lod of 3, or 1000:1 odds in favor of linkage, to be accepted: so that the a posteriori odds of linkage are 20:1 in favor. In the case of simultaneously mapping k loci of similar frequency, a comparable approximation is to take the a priori odds against linkage to a set of k intervals to be (5) Using the proposed thresholds, Table 2 shows the number of families needed to prove that a set of k loci found in this manner adequately accounts for occurrences of a trait. Such a finding would be strong evidence that the trait in question actually is genetic-which for certain disorders would be the most important discovery. It would also justify more extensive studies to prove or disprove the involvement of each of the k loci, by using the method above.
An Illustration. Consider a heterogeneous dominant trait caused (equally often) by mutations at any of three loci and suppose that we have available a 22-cM RFLP linkage map and families with n = 3 informative meioses.
With a priori reasons to suspect the correct three loci, we require 10 families on average to obtain 1000:1 odds for our guess in the ensemble test. (Without a prior hypothesis, 18 families would be needed to obtain 1000:1 odds in favor of a triple of loci obtained by searching the data.) Showing that a particular one of the three loci is in fact involved requires 21 families.
By contrast, showing involvement of a locus with a = 0.33 without simultaneous mapping would require 37 families ifwe were to use flanking RFLP markers and 49 if we were to insist on using single unmapped markers.
DISCUSSION
The mathematical methods we describe here to exploit the full information contained in an RFLP map considerably reduce the number of families needed to study a human trait. The main conclusions that emerge from the data are as follows:
(i) Interval mapping is more efficient than using single markers. With a 52-cM map, one needs about 40% fewer families to detect linkage to a dominant trait and about 60% for a recessive trait. With a 22-cM map, the reductions are about 25% and 40%, respectively. In addition to these savings in the number of families needed to find the correct region, fewer DNA probings are required to reject unlinked regions when an RFLP map is used (data not shown).
(ii) Simultaneous search is more efficient than studying single loci alone. By exploiting the completeness of the RFLP map, we require about one-third as many families for typical tasks as if we used single unmapped markers. (Relative to using flanked intervals but nonsimultaneous methods, the savings are twofold.) (iii) Heterogeneity is far easier to detect by using a map. Between 1/5th and 1/50th as many families are required for typical problems. In practice, detecting heterogeneity without an RFLP map may be somewhere between impractical and impossible. Heterogeneity is so much easier to detect with interval mapping, because it gives rise to outcomes that can be rationalized only as rare double crossovers if we insist on homogeneity.
The savings in the number of families needed is not simply a matter of economics. With genetic markers no longer a major constraint, finding enough families with multiple affected members will pose the greatest limitation to the study of human heredity. Reducing these requirements by using information in a more powerful way may bring some complex human traits within the realm of molecular analysis.
